ACHC
Acadia Healthcare Company, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Feb 25 Acadia Healthcare reported a significant net loss of $12.16 per shar…
- R Apr 7 The California Court of Appeal affirmed a $9 million jury verdict ag…
- R Apr 29 Acadia Healthcare reported Q1 2026 adjusted EPS of $0.37, beating co…
- R May 18 Acadia Healthcare disclosed that a California jury awarded $105 mill…
- A Jun 3 Jefferies upgrades
- I Jun 30 3 funds open new positions (13F)
- R Jul 28 Acadia Healthcare reported Q2 2026 adjusted EPS of $0.38, beating co…
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 38 added (3 new), 29 trimmed or exited. Largest new: Macquarie Group $15.4M, Bank Of Nova Scotia $14.6M.
- AnalystsBULLISH
13 of 20 rate it Buy or better.
- Short sellersSTEADY
Short interest +5.9% to 22.77M shares. 13.9 days to cover, ≈24.5% of shares.
- TrendUPTREND
9% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| BlackRock, Inc. | ADD | $441.7M |
| WELLINGTON MANAGEMENT GROUP LLP | TRIM | $169.1M |
| FMR LLC | TRIM | $148.1M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | DOUBLED | $124.6M |
| UBS Group AG | ADD | $119.4M |
| DIMENSIONAL FUND ADVISORS LP | ADD | $118.5M |
| AMERICAN CENTURY COMPANIES INC | DOUBLED | $85.9M |
| GOLDMAN SACHS GROUP INC | ADD | $84.8M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
20 analysts| Date | Firm | Rating |
|---|---|---|
| Sep 23, 2026 | Leerink Partners MAINTAIN | Market Perform |
| Jul 30, 2026 | Guggenheim MAINTAIN | Buy |
| Jul 30, 2026 | Barclays MAINTAIN | Equal-Weight |
| Jul 20, 2026 | Guggenheim MAINTAIN | Buy |
| Jul 14, 2026 | TD Cowen MAINTAIN | Buy |
| Jul 14, 2026 | Keybanc MAINTAIN | Overweight |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 26, 2026 | Farley Brian EVP, CLAO and Secretary | TAX W/H | $61.1K |
| Jun 26, 2026 | Farley Brian EVP, CLAO and Secretary | TAX W/H | $35.9K |
| May 6, 2026 | GRIECO WILLIAM Director | AWARD | 6,331 sh |
| May 6, 2026 | KELLY RALPH DAVID Director | AWARD | 6,331 sh |
| May 6, 2026 | Bissell E. Perot Director | AWARD | 6,331 sh |
| May 6, 2026 | Gregg Vicky B Director | AWARD | 6,331 sh |
| May 6, 2026 | Bernhard Jason Director | AWARD | 6,331 sh |
| May 6, 2026 | Cancelmi Daniel J Director | AWARD | 6,331 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data — subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data — subscribers only | |||
| Next Q | 🔒 Fresh data — subscribers only | |||
| Current FY | 🔒 Fresh data — subscribers only | |||
| Next FY | 🔒 Fresh data — subscribers only | |||
Short side
FINRA· Sep 30, 2026SecBot reports
10 filings · 1 bullish · 3 bearish · 2 mixed · 4 neutral- NEUTRAL SC 13GOct 8, 2026
Dimensional Fund Advisors LP disclosed a 5.0% passive stake in Acadia Healthcare Company, Inc. as…
Monitor for any future amendments to this 13G that show an increase or decrease in Dimensional's stake, which could signal a change in conviction. As a passive filing from a large index-oriented…
- NEUTRAL 8-KSep 25, 2026
Acadia Healthcare has reached a settlement in three stockholder derivative actions (Federal…
The settlement removes a multi-year overhang from derivative litigation, but the $12M cash payment is funded by insurance (not company cash) and governance reforms are incremental. Monitor the…
- MIXED INST-CLUSTERAug 6, 2026
Institutional 13F cluster for ACHC shows mixed conviction in Q2 2026: two asset managers…
The institutional cluster is net bearish but not overwhelming — Citigroup's near-exit is the dominant signal, while two smaller asset managers added. The raised cash flow guidance provides a…
- MIXED 8-KJul 28, 2026
Acadia Healthcare reported Q2 2026 adjusted EPS of $0.38, beating consensus of $0.35 by 8.6%, but…
The beat on adjusted EPS and the raised guidance (especially the large operating cash flow upgrade) provide a near-term positive catalyst, but the 26% YoY decline in Adjusted EBITDA and the PLGL…
All ACHC filing & press-release reports (10)
- SC 13G reportOct 8, 2026
- 8-K reportSep 25, 2026
- INST-CLUSTER reportAug 6, 2026
- 8-K reportJul 28, 2026
- COURT-RULING reportMay 27, 2026
- 8-K reportMay 18, 2026
- 8-K reportApr 29, 2026
- COURT-RULING reportApr 7, 2026
- DEFA14A reportMar 25, 2026
- 8-K reportFeb 25, 2026